Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
38.50
-0.41 (-1.05%)
Dec 5, 2025, 4:00 PM EST - Market closed
Mineralys Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Cash & Equivalents | 217.6 | 114.09 | 49.3 | 87.7 | 10.61 | 1.41 |
| Short-Term Investments | 376.03 | 84.1 | 187.26 | 22.41 | - | - |
| Cash & Short-Term Investments | 593.63 | 198.19 | 236.57 | 110.11 | 10.61 | 1.41 |
| Cash Growth | 125.20% | -16.22% | 114.85% | 937.60% | 653.16% | - |
| Prepaid Expenses | 6.17 | 7.16 | 12.54 | 2.7 | 0.46 | 0.06 |
| Restricted Cash | - | - | - | - | 0.05 | - |
| Total Current Assets | 599.8 | 205.35 | 249.1 | 112.81 | 11.12 | 1.47 |
| Property, Plant & Equipment | 0.01 | 0.05 | - | - | - | - |
| Long-Term Investments | - | - | 2.48 | - | - | - |
| Long-Term Deferred Charges | - | 0.4 | - | 1.6 | 0 | - |
| Other Long-Term Assets | 0.14 | 0.1 | 0.05 | 0.03 | - | 0.02 |
| Accounts Payable | 1.12 | 0.48 | 0.6 | 1.91 | 0.76 | 0.53 |
| Accrued Expenses | 22.4 | 14.17 | 9.88 | 6.16 | 4.29 | 0.05 |
| Short-Term Debt | - | - | - | - | - | 4.5 |
| Total Current Liabilities | 23.52 | 14.65 | 10.48 | 8.07 | 5.05 | 5.08 |
| Common Stock | 0.01 | 0.01 | 0 | 0 | 0 | 0.01 |
| Additional Paid-In Capital | 1,001 | 493.77 | 365.86 | 0.54 | 0.09 | - |
| Retained Earnings | -424.94 | -302.52 | -124.71 | -52.81 | -23.01 | -3.6 |
| Total Common Equity | 576.43 | 191.26 | 241.15 | -52.27 | -22.93 | -3.6 |
| Total Liabilities & Equity | 599.95 | 205.9 | 251.64 | 114.44 | 11.13 | 1.49 |
| Total Debt | - | - | - | - | - | 4.5 |
| Net Cash (Debt) | 593.63 | 198.19 | 236.57 | 110.11 | 10.61 | -3.09 |
| Net Cash Growth | 125.20% | -16.22% | 114.85% | 937.60% | - | - |
| Net Cash Per Share | 9.92 | 4.08 | 6.54 | 21.31 | 2.13 | -0.67 |
| Filing Date Shares Outstanding | 79.14 | 49.84 | 49.63 | 40.86 | 5.44 | 4.63 |
| Total Common Shares Outstanding | 78.97 | 49.82 | 41.13 | 6.42 | 5.44 | 4.63 |
| Working Capital | 576.28 | 190.71 | 238.62 | 104.74 | 6.07 | -3.62 |
| Book Value Per Share | 7.30 | 3.84 | 5.86 | -8.14 | -4.21 | -0.78 |
| Tangible Book Value | 576.43 | 191.26 | 241.15 | -52.27 | -22.93 | -3.6 |
| Tangible Book Value Per Share | 7.30 | 3.84 | 5.86 | -8.14 | -4.21 | -0.78 |
Source: S&P Capital IQ. Standard template.
Financial Sources.